BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32485281)

  • 1. Effect of Carbonic Anhydrase IX inhibitors on human endothelial cell survival.
    Genah S; Angeli A; Supuran CT; Morbidelli L
    Pharmacol Res; 2020 Sep; 159():104964. PubMed ID: 32485281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia.
    McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S
    Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potentiated cooperation of carbonic anhydrase IX and histone deacetylase inhibitors against cancer.
    Ruzzolini J; Laurenzana A; Andreucci E; Peppicelli S; Bianchini F; Carta F; Supuran CT; Romanelli MN; Nediani C; Calorini L
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):391-397. PubMed ID: 31865754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy.
    Andreucci E; Ruzzolini J; Peppicelli S; Bianchini F; Laurenzana A; Carta F; Supuran CT; Calorini L
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):117-123. PubMed ID: 30362384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of novel isoindoline-1,3-dione-based oximes and benzenesulfonamide hydrazones as selective inhibitors of the tumor-associated carbonic anhydrase IX.
    Abdel-Aziz AA; El-Azab AS; Abu El-Enin MA; Almehizia AA; Supuran CT; Nocentini A
    Bioorg Chem; 2018 Oct; 80():706-713. PubMed ID: 30064081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of carbonic anhydrase-IX by sulphonamide derivatives induces pH and reactive oxygen species-mediated apoptosis in cervical cancer HeLa cells.
    Koyuncu I; Gonel A; Kocyigit A; Temiz E; Durgun M; Supuran CT
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1137-1149. PubMed ID: 30001631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective Anticancer Potential of a New Sulfonamide as a Carbonic Anhydrase IX Inhibitor Against Aggressive Tumors.
    Koyuncu I; Temiz E; Güler EM; Durgun M; Yuksekdag O; Giovannuzzi S; Supuran CT
    ChemMedChem; 2024 May; 19(9):e202300680. PubMed ID: 38323458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: Design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumor agents.
    Eldehna WM; Abo-Ashour MF; Nocentini A; El-Haggar RS; Bua S; Bonardi A; Al-Rashood ST; Hassan GS; Gratteri P; Abdel-Aziz HA; Supuran CT
    Eur J Med Chem; 2019 Jan; 162():147-160. PubMed ID: 30445264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors.
    Supuran CT
    Expert Opin Investig Drugs; 2018 Dec; 27(12):963-970. PubMed ID: 30426805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs.
    Carta F; Vullo D; Osman SM; AlOthman Z; Supuran CT
    Bioorg Med Chem; 2017 May; 25(9):2569-2576. PubMed ID: 28347633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform.
    Ibrahim HS; Allam HA; Mahmoud WR; Bonardi A; Nocentini A; Gratteri P; Ibrahim ES; Abdel-Aziz HA; Supuran CT
    Eur J Med Chem; 2018 May; 152():1-9. PubMed ID: 29684705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis.
    Andreucci E; Peppicelli S; Carta F; Brisotto G; Biscontin E; Ruzzolini J; Bianchini F; Biagioni A; Supuran CT; Calorini L
    J Mol Med (Berl); 2017 Dec; 95(12):1341-1353. PubMed ID: 28929255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors.
    Morris JC; Chiche J; Grellier C; Lopez M; Bornaghi LF; Maresca A; Supuran CT; Pouysségur J; Poulsen SA
    J Med Chem; 2011 Oct; 54(19):6905-18. PubMed ID: 21851094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyridazinone-substituted benzenesulfonamides display potent inhibition of membrane-bound human carbonic anhydrase IX and promising antiproliferative activity against cancer cell lines.
    Krasavin M; Shetnev A; Baykov S; Kalinin S; Nocentini A; Sharoyko V; Poli G; Tuccinardi T; Korsakov M; Tennikova TB; Supuran CT
    Eur J Med Chem; 2019 Apr; 168():301-314. PubMed ID: 30826507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative assessment of specific carbonic anhydrase inhibitors effect on hypoxic cells using electrical impedance assays.
    Stanica L; Gheorghiu M; Stan M; Polonschii C; David S; Bratu D; Dinischiotu A; Supuran CT; Gheorghiu E
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1079-1090. PubMed ID: 28783982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the antiproliferative and apoptotic roles of sulfonamide carbonic anhydrase IX inhibitors in HeLa cancer cell line.
    Koyuncu I; Gonel A; Durgun M; Kocyigit A; Yuksekdag O; Supuran CT
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):75-86. PubMed ID: 30362386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of 4-Hydroxy-3-(3-(phenylureido)benzenesulfonamides as SLC-0111 Analogues for the Treatment of Hypoxic Tumors Overexpressing Carbonic Anhydrase IX.
    Bozdag M; Carta F; Ceruso M; Ferraroni M; McDonald PC; Dedhar S; Supuran CT
    J Med Chem; 2018 Jul; 61(14):6328-6338. PubMed ID: 29962205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of carbonic anhydrase IX over carbonic anhydrase XII in breast cancer cells using benzene sulfonamides: Disconnect between activity and growth inhibition.
    Mboge MY; Chen Z; Wolff A; Mathias JV; Tu C; Brown KD; Bozdag M; Carta F; Supuran CT; McKenna R; Frost SC
    PLoS One; 2018; 13(11):e0207417. PubMed ID: 30452451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-ray crystallography of Epacadostat in adduct with Carbonic Anhydrase IX.
    Angeli A; Peat TS; Selleri S; Saleh Alfawaz Altamimi A; Supuran CT; Carta F
    Bioorg Chem; 2020 Apr; 97():103669. PubMed ID: 32088421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the anticancer potential of a sulphonamide carbonic anhydrase IX inhibitor on cervical cancer cells.
    Koyuncu I; Tülüce Y; Slahaddin Qadir H; Durgun M; Supuran CT
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):703-711. PubMed ID: 30810431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.